<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01251185</url>
  </required_header>
  <id_info>
    <org_study_id>ESMR CHF-IL</org_study_id>
    <nct_id>NCT01251185</nct_id>
  </id_info>
  <brief_title>Extracorporeal Shockwave Myocardial Revascularization (ESMR) Therapy For The Treatment of Chronic Heart Failure</brief_title>
  <official_title>Extracorporeal Shockwave Myocardial Revascularization(ESMR)Therapy For The Treatment of Chronic Heart Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medispec</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medispec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of non-invasive treatment modality, using low-intensity extracorporeal shockwaves&#xD;
      for treatment of subjects diagnosed with Congestive Heart Failure, with ischemic etiology.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change in the number of myocardial segments that improve their contractility(at rest and at stress)at 6 months post baseline evaluations, evaluated by echocardiography.</measure>
    <time_frame>6 months</time_frame>
    <description>An echo examination shall be used to evaluate myocardial contractility post treatments.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 Minutes Walk Test (6MWT)</measure>
    <time_frame>6 months</time_frame>
    <description>Evaluation of 6MWT time from baseline to 6 months post baseline.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>CHF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-arm, open label, subjects with Congestive Heart Failure, with ischemic etiology.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardiospec</intervention_name>
    <description>Non-invasive, low-intensity extracoporeal shockwaves at energy density of 0.99 mJ/mm2. 9 treatment sessions, 20 minutes each, over a period of 9 weeks (3 sessions on weeks 1, 5 and 9).</description>
    <arm_group_label>CHF</arm_group_label>
    <other_name>Cardiospec ESMR therapy</other_name>
    <other_name>Extracorporeal Shockwave therapy</other_name>
    <other_name>Extracorporeal myocardial Revascularization</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient is male or female 18 years or older.&#xD;
&#xD;
          2. Patient is diagnosed with a Heart Failure with ischemic etiology. Diagnosis is based&#xD;
             on medical history, complete physical evaluation, and echocardiography.&#xD;
&#xD;
          3. Patient has documented myocardial segments with impaired contractility. Diagnosis is&#xD;
             based on Rest Echo.&#xD;
&#xD;
          4. Patient is diagnosed with no more than 50% of segments akinetic or dyskinetic&#xD;
             Diagnosis is based on echocardiography.&#xD;
&#xD;
          5. Patient is classified as NYHA II to IV.&#xD;
&#xD;
          6. Patient should be on a stable dosage of medication for at least 6 weeks prior to&#xD;
             enrollment.&#xD;
&#xD;
          7. Patients Ejection Fraction &lt; 50%.&#xD;
&#xD;
          8. Patient is stable and without clinical events for &gt; 3 months.&#xD;
&#xD;
          9. Patient has signed an informed consent form.&#xD;
&#xD;
         10. Patient's condition should be stable and should have a life expectancy of &gt;12 months.&#xD;
&#xD;
         11. Patient's current and past medical condition and status will be assessed using&#xD;
             previous medical history, physical evaluation, and the physicians (principle&#xD;
             investigator's)medical opinion.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient with intraventricular thrombus.&#xD;
&#xD;
          2. Severe COPD (patients with an FEV1 less than .8 liters).&#xD;
&#xD;
          3. Patient has chronic lung disease including emphysema and pulmonary fibrosis.&#xD;
&#xD;
          4. Patient has active endocarditis, myocarditis or pericarditis.&#xD;
&#xD;
          5. Patient is simultaneously participating in another device or drug study, or has&#xD;
             participated in any clinical trial involving an experimental device or drug, including&#xD;
             other drugs or devices enhancing cardiac neovascularization or any ESWT machine for&#xD;
             neovascularization of a competitor company within 3 months of entry into the study.&#xD;
&#xD;
          6. Patients who are unwilling or unable to cooperate with study procedure.&#xD;
&#xD;
          7. Patients who are unwilling to quit smoking during the study procedure (including&#xD;
             screening phase).&#xD;
&#xD;
          8. Patients who are diagnosed with severe valvular disease (regurgitation or stenosis).&#xD;
&#xD;
          9. Patient is pregnant.&#xD;
&#xD;
         10. Patient with a malignancy in the area of treatment without complete remission within 5&#xD;
             years(lungs, thorax, ribs).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hilton Miller, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel Aviv Souraski Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tel Aviv Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <study_first_submitted>November 30, 2010</study_first_submitted>
  <study_first_submitted_qc>November 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2010</study_first_posted>
  <last_update_submitted>February 17, 2013</last_update_submitted>
  <last_update_submitted_qc>February 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Extracorporeal Shockwave Therapy</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Congestive Heart Failure</keyword>
  <keyword>Non-invasive</keyword>
  <keyword>Device Trial</keyword>
  <keyword>NYHA (New York Heart Association)</keyword>
  <keyword>Ischemic cardiomyopathy</keyword>
  <keyword>Ischemia</keyword>
  <keyword>Myocardial contractility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

